Tag

Event-Driven Archives | Page 10 of 186 | Smartkarma

Daily Brief Event-Driven: Dongfeng (489 HK): Questioning The EV Listing Valuation and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Dongfeng (489 HK): Questioning The EV Listing Valuation
  • A/H Premium Tracker (To 5 Sep 2025):  AH Premia Contract Slightly, Beautiful Skew Better
  • Ecopro Co: Pursuing a PRS Deal Worth About 700 Billion Won Using Its Stake in Ecopro BM
  • Nidec: Navigating Regulatory Challenges and Unlocking Value
  • Timing and Hedge Play on Korea’s Top Policy Swing—CGT Applicable Threshold
  • Assura Thing: PHP’s Clean-Up Basis into October


Dongfeng (489 HK): Questioning The EV Listing Valuation

By David Blennerhassett

  • Back on the 22nd August, SOE-backed Dongfeng Motor (489 HK) announced a privatisation; together with a concurrent listing of its EV arm, VOYAH.
  • The share price closed up 54% on the first day, ~15% adrift of the independently valued cash + scrip (into VOYAH) under the privatisation.  
  • Shares have pared back 5% since. VOYAH’s peer basket has fallen ~15% on average. The market is implying a price-to-trailing-sales of 1x for VOYAH versus the basket average of 1.9x. 

A/H Premium Tracker (To 5 Sep 2025):  AH Premia Contract Slightly, Beautiful Skew Better

By Travis Lundy

  • “Beautiful Skew” came back slightly. Not huge, but OK. On average, liquid Hs outperformed their As by 0.8%.
  • Last week’s short reco on Remegen (9995 HK) gained 8.3% on the week in Hs and the H underperformed the A by 7% Friday to Friday, 4.5% if VWAPed Monday.
  • AH premia are likely still in a widening phase but weakness in speculative A-shares may dampen overall moves even if pairs are volatile. New reco this week.

Ecopro Co: Pursuing a PRS Deal Worth About 700 Billion Won Using Its Stake in Ecopro BM

By Douglas Kim

  • Several local news outlets reported that Ecopro Co is pursuing a plan to raise about 700 billion won through a PRS agreement using its stake in Ecopro BM as collateral.
  • Ecopro BM currently has a market cap of 11.4 trillion won. A PRS worth 700 billion won (assuming no change in share price), represents 6.1% of Ecopro BM’s market cap. 
  • Although Ecopro has not officially announced this PRS deal, we believe that this is a high probability (70%-80%+) that this deal will get done in the next several weeks.

Nidec: Navigating Regulatory Challenges and Unlocking Value

By Jay Cameron

  • Urgent Regulatory Deadline: Nidec faces a critical deadline of September 26, 2025. Meeting this deadline is crucial to avoid regulatory consequences, including potential “Security on Alert” designation or stock suspension.
  • Underlying Strength Amidst Issues: Despite recent compliance issues that have impacted its stock, Nidec maintains a strong position as a global leader in electric motors with diversified revenue, projected growth.
  • Potential for Rebound: The current low valuation, may present a buying opportunity for long-term investors if the company successfully addresses its governance issues and restores investor confidence.

Timing and Hedge Play on Korea’s Top Policy Swing—CGT Applicable Threshold

By Sanghyun Park

  • Deputy PM Koo guided the threshold decision by month-end, likely before Chuseok; historically, Seoul drops major policy prints on Thu/Fri, pointing to 25–26 as the high-prob window.
  • Local intel points to ₩5bn; strong public pushback makes it politically locked. Traders are positioning ahead of the 25–26 window, balancing index longs with hedges.
  • FSS break-up creates regulatory uncertainty, pressuring banks and brokers. Traders appear to be pairing index longs with financials shorts, riding policy momentum while hedging sector risk.

Assura Thing: PHP’s Clean-Up Basis into October

By Jesus Rodriguez Aguilar

  • The deal has moved into its closing stretch, with process milestones largely secured. From here, this feels more like a basis clean-up than a binary event, with execution discipline paramount.
  • Value now leans on PHP shares rather than regulatory drama. Hedging the stock leg frames the opportunity; avoiding complexity and timing slippage likely matters more than squeezing every basis point.
  • Squeeze-Out is advancing; settlement expected in October as delisting completes. I recommend treating CMA headlines as background noise and keeping sizing disciplined.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Regarding the Six KRX Sector Names that Ran Ahead of Friday’s Official Review Drop and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Regarding the Six KRX Sector Names that Ran Ahead of Friday’s Official Review Drop
  • Merger Arb Mondays (08 Sep) – Kangji, OneConnect, Ashimori, Pacific Ind, RPM, Santos, Zeekr
  • Weekly Deals Digest (07 Sep) – Pacific Industrial, Ashimori, Shibaura, Kangji Medical, Chery, Hesai
  • [Japan M&A] Pacific Industrial (7250) The MBO Is Extended After Effissimo Buys Above Terms
  • BBVA-Sabadell: Deal Launches Underwater, Arbitrage Still Asymmetric
  • TaskUs Privatization Faces Opposition Amid Potential for Improved Offer and Valuation Discrepancies
  • Weekly Update (CON, HNZ, BRSL)


Regarding the Six KRX Sector Names that Ran Ahead of Friday’s Official Review Drop

By Sanghyun Park

  • Six names stood out with simultaneous volume spikes and sharp pops last Friday; all Semis and Autos additions with big passive impact, while all others showed no tape action.
  • Results likely leaked early, prompting front-running on Semis and Autos adds—high passive impact names—causing Friday’s sharp volume and price spikes.
  • Early movers are mostly priced in; Thursday momentum plays still work, but Monday–Thursday morning requires caution. Focus on volume-driven flows before loading positions, long-short basket viable for other passive-impact names.


Weekly Deals Digest (07 Sep) – Pacific Industrial, Ashimori, Shibaura, Kangji Medical, Chery, Hesai

By Arun George


[Japan M&A] Pacific Industrial (7250) The MBO Is Extended After Effissimo Buys Above Terms

By Travis Lundy

  • Activist-Ish-Y investor Effissimo reported Friday they had a 6.68% stake as of the end of August. 
  • Their average price is ¥2,253 which is 10% through the price the family Bidco was bidding (¥2,050). 
  • As this hasn’t traded below terms at any point since announcement, an extension was likely. This morning, we got one. We’ll get another one before it’s done, BUT…

BBVA-Sabadell: Deal Launches Underwater, Arbitrage Still Asymmetric

By Jesus Rodriguez Aguilar

  • BBVA’s bid goes live on 8 Sept, but a –8.71% spread and poor optics keep tactical long SAB / short BBVA trades attractive.
  • Sabadell continues to boost standalone appeal via dividends, TSB sale, and strategic capital returns, reducing shareholder incentive to tender at current terms.
  • Legal overhang and merger restrictions extend into 2028, capping synergies and reinforcing the asymmetry in event-driven positioning ahead of potential bid adjustments.

TaskUs Privatization Faces Opposition Amid Potential for Improved Offer and Valuation Discrepancies

By Special Situation Investments

  • TaskUs is being privatized by Blackstone and founders at $16.50/share, opposed by activists and ISS, expecting improved offer.
  • TaskUs projects $75-$120 million free cash flow in 2025, potentially funding the buyout with minimal additional investment.
  • TaskUs specializes in premium BPO services, showing strong growth in Trust & Safety and AI Services segments, less vulnerable to automation.

Weekly Update (CON, HNZ, BRSL)

By Richard Howe

  • On September 2, 2025, Kraft Heinz (KHC) announced that it will be breaking up into two companies.
  • The news comes a decade after the infamous merger of two of the biggest names in packaged foods that was orchestrated by Warren Buffett and Brazilian private equity firm 3G Capital Partners.
  • North American Grocery Co would encompass many of the traditional Kraft products.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Last Week In Event SPACE: ZEEKR/Geely and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Last Week In Event SPACE: ZEEKR/Geely, Kangji Medical, HKBN, Lynas, Huaxin Cement, Nidec
  • (Mostly) Asia-Pac M&A: Peak Rare Earths, Yutaka Giken, Shibaura, Johns Lyng, Ainsworth, Ashimori


Last Week In Event SPACE: ZEEKR/Geely, Kangji Medical, HKBN, Lynas, Huaxin Cement, Nidec

By David Blennerhassett


(Mostly) Asia-Pac M&A: Peak Rare Earths, Yutaka Giken, Shibaura, Johns Lyng, Ainsworth, Ashimori

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: [Japan CorpGov] TSE “Mgmt Conscious” Reports (Sep25) and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • [Japan CorpGov] TSE “Mgmt Conscious” Reports (Sep25), TSE Presents Interesting Feedback
  • Peak Rare Earths (PEK AU): Shenghe Bumps And Declares Terms Final
  • Merger and Acquisition Updates: TaskUs, scPharmaceuticals, Apiam, Plymouth, Mayne Pharma, Banxa, and DallasNews
  • A Block Deal Sale of 1.4 Trillion Won of Hanwha Ocean Shares by Hanwha Impact Partners
  • POSCO: Reviewing a Potential M&A of HMM


[Japan CorpGov] TSE “Mgmt Conscious” Reports (Sep25), TSE Presents Interesting Feedback

By Travis Lundy

  • TSE-Listed companies are asked to file “Management Conscious of Capital Cost/Stock Price” awareness reports/policies. Many have. Some are still working on it. And policies change, and CGR reports are updated.
  • 216 new CGRs filed in Aug-2025 (after 783 in July, 1,389 in June). Our tools show every report, links to every document, and a diff-file tool. Input name, see changes.
  • The JPX Council of Experts met on 2 Sep (and 9 July before that). The parent-sub changes are slow to come. 2 Sep docs may be worth reading in parts.

Peak Rare Earths (PEK AU): Shenghe Bumps And Declares Terms Final

By David Blennerhassett

  • On the 15th May, Peak Rare Earths (PEK AU) entered into a non-binding Offer, by way of a Scheme, with Shenghe Resources (600392 CH) @A$0.389/share, a punchy 199% to undisturbed.
  • Shenghe holds 19.86% in Peak, and has offtake rights to 100% of the rare earth production from the 84%-held Ngualla project in Tanzania. 
  • The Scheme Booklet was registered with ASIC on the 11th August with a 16th September Scheme Meeting. Shenghe has now bumped terms to A$0.443. Declared final. Scheme Meeting remains unchanged. 

Merger and Acquisition Updates: TaskUs, scPharmaceuticals, Apiam, Plymouth, Mayne Pharma, Banxa, and DallasNews

By Special Situation Investments

  • TaskUs privatization bid at $16.50/share faces opposition; market anticipates improved offer before September 10 shareholder vote.
  • Apiam Animal Health receives A$0.88/share takeover offer; largest shareholder supports, board likely to recommend upon binding agreement.
  • Banxa shareholders approve OSL Group acquisition; regulatory consents pending, closing expected Q4’25–Q1’26, spread at 21%.

A Block Deal Sale of 1.4 Trillion Won of Hanwha Ocean Shares by Hanwha Impact Partners

By Douglas Kim

  • Hanwha Impact Partners sold 1.4 trillion won worth of Hanwha Ocean shares in a block deal sale. 
  • Hanwha Ocean’s share price closed down at 5.4% to 112,500 won on the KRX exchange today but still 5% higher than block deal price of 107,100 won. 
  • We believe that this block deal sale of 1.4 trillion won worth of Hanwha Ocean is likely to have a near-term negative impact on Hanwha Ocean’s stock price.

POSCO: Reviewing a Potential M&A of HMM

By Douglas Kim

  • The biggest potential M&A event right now in Korea is the potential acquisition of HMM Co., Ltd. (011200 KS) by POSCO Holdings (005490 KS).
  • Overall, we believe there is a higher probability of POSCO backing out of this potential acquisition of HMM, rather than POSCO completing this M&A deal.
  • Although POSCO claims that it spends about 3 trillion won annually on logistics, the actual synergies among these three businesses (steel, rechargeable battery, and logistics) remain murky.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Kangji Medical (9997 HK): Speedy Turnaround On Pre-Cons and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Kangji Medical (9997 HK): Speedy Turnaround On Pre-Cons
  • Potential Spillover Trades from Next Month’s KOSDAQ150 Weeklies Launch
  • Tracing Korea’s Flow Dynamics: Short-Term Sector Rotation Plays
  • Pop Mart (9992 HK): Index Inclusion & Beyond. Toy Craze or Emerging ACG Play?
  • SK Chemicals: A Potential EB Issue of 240 Billion Won Using Its Stake in SK Bioscience
  • Harim Holdings – EB Issue of Its Treasury Shares for 143 Billion Won
  • MannKind’s Acquisition of scPharmaceuticals: Strategic CVR Valuation and FDA Approval Prospects for SCP-111


Kangji Medical (9997 HK): Speedy Turnaround On Pre-Cons

By David Blennerhassett

  • Kangji Medical Instrument (9997 HK) announced last night all pre-cons have been squared away. That must be some kind of record to secure SAMR approval for a Hong Kong-listed privatisation.
  • Back on the 12th August, Kangji Medical announced a less-than-ideal Offer, by way of a Scheme, from a consortium led by TPG and Qatar Investment Authority, together with the founders.
  • What next? The Scheme Doc dispatch remains the 31st October, unless announced otherwise, as the Cayman Court is still on its six week “vacation”.

Potential Spillover Trades from Next Month’s KOSDAQ150 Weeklies Launch

By Sanghyun Park

  • KRX plans to list KOSDAQ150 weekly options next month, likely October 27, and is lining up market makers to ensure two-way liquidity from day one.
  • Early volumes for KOSDAQ150 weeklies will be thin, making MMs cautious, but some may step in despite risks.
  • Early KOSDAQ150 weeklies could trigger spillover trades, as thin volumes and active MMs lead to IV–spot gaps, price dislocations, and triangular arbitrage opportunities.

Tracing Korea’s Flow Dynamics: Short-Term Sector Rotation Plays

By Sanghyun Park

  • Korea’s seeing classic sector rotation: H1 hot money is exiting shipbuilding and defense ETFs, with 7% of AUM out in a week, as traders hunt the next wave of flows.
  • Short-Term plays focus on two angles: policy-driven sectors like retail/dividends, and less-run names. Secondary batteries lead flows, topping local sector ETF net inflows lately.
  • Sector rotation trades focus on Sept 11 rebalances: TIGER Secondary Battery TOP 10 and KRX Semis. Long-short setups on top names plus rotation flows could spark notable price moves.

Pop Mart (9992 HK): Index Inclusion & Beyond. Toy Craze or Emerging ACG Play?

By Devi Subhakesan

  • Pop Mart (9992 HK) will be added to both the Hang Seng Index (HSI) and the Hang Seng China Enterprises Index (HSCEI) — effective Monday, September 8, 2025.
  • Beyond the tail winds from this technical upgrade, stock’s further upside rests on investor conviction on its potential to continue to deliver strong growth beyond the short term.
  • Pop Mart’s near term growth rests on proving IP durability and executing global scale-up.

SK Chemicals: A Potential EB Issue of 240 Billion Won Using Its Stake in SK Bioscience

By Douglas Kim

  • Hankyung Business Daily reported today that SK Chemicals (285130 KS) is pursuing an issuance of exchangeable bonds (EB) worth 240 billion won using its stake in SK Bioscience (302440 KS). 
  • SK Chemicals has not officially announced its plans to issue such EB which is likely to have a positive impact on SK Chemicals and negative impact on SK Bioscience.
  • SK Chemicals’ market cap is now 1.1 trillion won. Its 66.4% stake in SK Bioscience is worth 2.6 trillion won. 

Harim Holdings – EB Issue of Its Treasury Shares for 143 Billion Won

By Douglas Kim

  • Harim Holdings (003380 KS) announced that it plans to sell its 14.744 million treasury shares through an issuance of EB worth 143 billion won. 
  • The EB exchange price is 9,713 won (15.6% higher than its current price). The company plans to use the EB proceeds to pay down debt and for working capital. 
  • We are NEGATIVE on Harim Holdings’ EB issue using its treasury shares as the main asset to be exchanged.

MannKind’s Acquisition of scPharmaceuticals: Strategic CVR Valuation and FDA Approval Prospects for SCP-111

By Special Situation Investments

  • MannKind acquires scPharmaceuticals for $5.35/share plus a CVR up to $1.00; market values CVR at $0.17.
  • SCP-111’s FDA approval is crucial for CVR value; pivotal trials complete with positive results, sNDA submission expected Q3 2025.
  • Sales milestone challenging; FUROSCIX revenue below $110m threshold; MannKind’s distribution network key for growth.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Ashimori Industry (3526 JP): Murakami Outlines His Case and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Ashimori Industry (3526 JP): Murakami Outlines His Case
  • Pacific Industrial (7250 JP): Effissimo Rears Its Head
  • LS Cable – To Issue an EB Worth 400 Billion Won Using LS Marine Solution as Base Asset?
  • Kangji Medical (9997 HK): Precondition Satisfied for the Light Scheme Offer
  • PC Partner (1263 HK): Thoughts On The HKEx Delisting
  • Johns Lyng (JLG AU): 8th October Vote On PEP’s Offer
  • Johns Lyng (JLG AU): Scheme Vote on 8 October
  • BMPS–Mediobanca: Sweetener + Waiver Tighten the Spread
  • 2025 High Conviction: QFIN US – Event-Driven: Regulatory Overhang Sets Up 100%+ Upside Post-Clarity


Ashimori Industry (3526 JP): Murakami Outlines His Case

By Arun George

  • Takateru Murakami, Yoshiaki Murakami’s son, has increased his Ashimori Industry (3526 JP) to an 18.36% ownership ratio at an average buy-in price of JPY4,154.28 vs. the JPY4,140 tender offer. 
  • Crucially, in today’s disclosure, Takateru Murakami outlines the rationale for his stake building, which centres on the book value being materially understated if certain land were revalued at market rates.
  • Maintaining current terms is increasingly not a viable option. Toyoda Gosei (7282 JP) is likely to pursue a strategy of either increasing its offer or lowering the minimum acceptance condition. 

Pacific Industrial (7250 JP): Effissimo Rears Its Head

By Arun George

  • Effissimo reported a 5.87% ownership ratio in Pacific Industrial (7250 JP). The average buy-in price of JPY2,235.91 per share is 9.1% above the JPY2,050 MBO offer.
  • Effissimo buying significantly above terms is justifiable as the offer implied a P/B of 0.71x. Effissimo is agitating for either a bump or an opportunity to participate in the back-end.
  • With the offer closing on 8 September and shares trading 16.9% above terms, the Ogawas have little choice but to revise terms.

LS Cable – To Issue an EB Worth 400 Billion Won Using LS Marine Solution as Base Asset?

By Douglas Kim

  • Major major local media including Maekyung Business Daily and Chosun Daily have reported that LS Cable & System is pushing forward with an EB worth 400 billion won. 
  • The target stock to be used in the EB is LS Cable’s shares in its subsidiary LS Marine Solution. 
  • LS Marine Solution is one of the largest marine engineering companies in Korea, specializing in the installation and maintenance of submarine cables, offshore wind infrastructure, and marine energy systems.

Kangji Medical (9997 HK): Precondition Satisfied for the Light Scheme Offer

By Arun George

  • The precondition for Hangzhou Kangji Medical Instrument Co., Ltd. (9997 HK)’s scheme privatisation from a consortium is satisfied. The offer, which has been declared final, is at HK$9.25 per share. 
  • The key condition will be approval by at least 75% disinterested shareholders (<10% of all disinterested shareholders rejection). Crucially, the blocking stake is below the substantial disclosure threshold.
  • Despite the recent derating of peers, the vote risk remains medium-to-high due to a solid interim, the imminent surgical robot growth story, unfavourable AGM voting patterns, and emerging retail opposition.

PC Partner (1263 HK): Thoughts On The HKEx Delisting

By David Blennerhassett

  • On the 15th November 2024, personal computer parts and accessories play PC Partner (1263 HK)‘s secondary listing, by way of introduction, was effected.
  • The SGX also granted in-principle approval for the conversion of its secondary listing status to a primary listing. This dual-listing status (SGX + HKEx) took effect on the 20th August.  
  • In tandem with a SGX free float waiver, PCP will now seek a HKEx delisting. This listing/delisting construct is to ensure the uninterrupted supply of NVIDIAs GPUs.

Johns Lyng (JLG AU): 8th October Vote On PEP’s Offer

By David Blennerhassett

  • On the 11th July, PEP offered A$4/share for integrated building services provider Johns Lyng (JLG AU), a 77% premium to undisturbed. CEO Scott Didier, JLG’s largest shareholder (17.62%), was supportive.
  • Pricing is okay. The absence of a final year fully franked dividend, which was teased at the onset, was ostensibly disappointing.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 8th October, and expected implementation on or before the 23rd October. The IE (Kroll) says “fair & reasonable“.

Johns Lyng (JLG AU): Scheme Vote on 8 October

By Arun George

  • The Johns Lyng (JLG AU) IE considers PEP’s A$4.00 offer fair and reasonable as it is within its A$3.72-4.42 valuation range.
  • The offer requires regulatory (FIRB and US) and shareholder approvals. The scheme vote should pass as no disinterested shareholder comes close to holding a blocking stake.  
  • The offer is reasonable as the timing of an earnings recovery is highly uncertain. At the last close and for a 23 October payment, the gross/annualised spread is 1.5%/11.0%. 

BMPS–Mediobanca: Sweetener + Waiver Tighten the Spread

By Jesus Rodriguez Aguilar

  • BMPS raises terms to 2.533 BMPS shares plus €0.90 cash per Mediobanca share, waiving the two-thirds condition while retaining a 35% minimum—shifting sentiment to a modest, positive convergence setup.
  • Timeline tight: board review this week; acceptance deadline 8 September; results and settlement mid-September unless terms change, which could trigger re-opening and push closing toward late September or early October.
  • Best expression remains long Mediobanca, short 2.533× BMPS per share; a 1% BMPS move shifts implied consideration ~€0.19 (≈1% of MB), so maintain a disciplined hedge into catalysts and headlines.

2025 High Conviction: QFIN US – Event-Driven: Regulatory Overhang Sets Up 100%+ Upside Post-Clarity

By Raj S, CA, CFA

  • QFIN US is down 30% since July on fear that the Oct 1 regulatory action on 24%+ loans will lead to significant and sustained earnings downgrades.
  • QFIN’s industry-leading franchise, risk management history, capital return yield (~18-20%), and strong balance sheet support a strong recovery post-regulatory clarity and cleanup.
  • Valuation at 1.2x FY1 P/BV already discounts worst case; QFIN’s recovery potential leaves scope for 100%+ upside (peak valuation at 2.4x in Mar-24 pre-regulation).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Holdco NAV Discount Compression Play on Korea’s Next Policy Narrative: Mandatory Tender Offers and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Holdco NAV Discount Compression Play on Korea’s Next Policy Narrative: Mandatory Tender Offers
  • Shibaura Electronics (6957 JP): Signed, Sealed, Delivered as Yageo Secures FEFTA Approval
  • Alipay: Issuing EB Worth 627 Billion Won Backed By Its Shares in Kakao Pay [A Quasi Block Deal Sale]
  • Mixue (2097 HK): Lock-Up Expiry. After Doubling Post-IPO, Is the Fizz Running Out?
  • ZEEKR (ZK US): Widening Scrip Spread Ahead Of Geely EGM Vote
  • Alpha Generation Through Share Buybacks in Korea: Bi-Monthly (July and August 2025)


Holdco NAV Discount Compression Play on Korea’s Next Policy Narrative: Mandatory Tender Offers

By Sanghyun Park

  • Korean equities are stalled; macro catalysts are absent. Street focus shifts from treasury share cancellations to next year’s mandatory tender offers, now seen as the top policy driver.
  • Pre-MTO trades focus on holding companies with wide NAV discounts or low controlling stakes, front-running policy-driven re-ratings before minority shareholders capture control premiums.
  • Focus on 32 Korean holding companies >KRW 500B; those with wide NAV discounts and lighter controlling stakes—SK’s holding companies, Samsung C&T, Hanwha, LG, LS—are prime re-rating plays.

Shibaura Electronics (6957 JP): Signed, Sealed, Delivered as Yageo Secures FEFTA Approval

By Arun George

  • Yageo Corporation (2327 TT) has finally secured FEFTA approval for its JPY7,130 offer for Shibaura Electronics (6957 JP). The close of the tender offer has been extended to 18 September.
  • The Board has opposed the Yageo offer due to synergies, dis-synergies and cultural differences. However, on 29 August, the Board’s update suggested a possible pathway to recommend Yageo’s offer.
  • Despite Minebea Mitsumi (6479 JP)’s tendency to go against its declarations and increase its offer on several occasions, this time it is different. Minebea is likely to exit.

Alipay: Issuing EB Worth 627 Billion Won Backed By Its Shares in Kakao Pay [A Quasi Block Deal Sale]

By Douglas Kim

  • Alipay (second largest shareholder of Kakaopay (377300 KS)) is issuing an overseas exchangeable bonds (EB) worth 627 billion won (backed by its shares in Kakao Pay).
  • The exchange price of the EB is 54,744 won (4.5% discount to current price).  Total amount of EB issue is 627 billion won ($450 million). 
  • This deal is basically a quasi-block deal. Alipay is trying to unload some of its stake in Kakao Pay to improve its finances.

Mixue (2097 HK): Lock-Up Expiry. After Doubling Post-IPO, Is the Fizz Running Out?

By Devi Subhakesan

  • The expiry of cornerstone investors’ lock-up today modestly increases Mixue Group (2097 HK)’s free float, which still remains below 10%.
  • Mixue’s 1H2025 results show limited overseas scale-up, with growth driven entirely by the domestic market, raising concerns over long-term growth prospects from new markets.
  • At 22x forward earnings, Mixue trades at a premium to HK-listed F&B peers, reflecting market optimism for above-consensus growth.

ZEEKR (ZK US): Widening Scrip Spread Ahead Of Geely EGM Vote

By David Blennerhassett

  • On the 15th July, Geely Auto (175 HK), China’s second-largest carmaker, firmed a cash or scrip Offer for 62.8%-held ZEEKR (ZK US), a premium Chinese electric vehicle manufacturer
  • ZEEKR has traded through the cash terms US$26.87/ADS from the onset; but at a discount to the scrip terms. The scrip spread has widened recently. 
  • The Offer is low-balled. However, Geely’s stake plus Li Shufu (founder)’s 10.61% holdings push the Offer through. Geely’s EGM is this Friday (7th July). Li (41.34%) is required to abstain. 

Alpha Generation Through Share Buybacks in Korea: Bi-Monthly (July and August 2025)

By Douglas Kim

  • In this insight, we discuss the alpha generation through companies that announced share buybacks in the Korean stock market in July and August 2025.
  • We provide a list of 29 companies in the Korean stock market that have announced share buyback programs in July and August 2025.
  • There were three companies with more than 1 trillion won in market cap that announced share buybacks in the past two months with at least 1% of outstanding shares.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Mayne Pharma (MYX AU): FY25 Results Aid Both Sides and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Mayne Pharma (MYX AU): FY25 Results Aid Both Sides
  • HKBN (1310 HK): On the Cusp of Being Declared Unconditional
  • Clearing up the FSS’s Sudden Call on Samsung Life’s Samsung Elec Stake Accounting Shift
  • Current Merger Arbitrage Opportunities and Strategic Reviews in Global Markets: Key Active Cases
  • A/H Premium Tracker (To 29 Aug 2025):  AH Premia Expand Again, Beautiful Skew Takes a Breather
  • Lynas (LYC AU) Targets Vertical Expansion
  • Huaxin Cement (6655 HK): Floats Non-Chinese Ops Spin-Off
  • Increasing Probability of Hanwha Group Selling Its 8% Stake in Korea Zinc
  • Merger Arbitrage Opportunities and Strategic Updates: AHX, PLYM, LWAY, YORKU, NZM, PAC and More
  • Apiam Animal Health Receives A$0.88/Share Takeover Offer from Adamantem Capital


Mayne Pharma (MYX AU): FY25 Results Aid Both Sides

By Arun George

  • On 29 August, Mayne Pharma (MYX AU) reported its FY25 results with underlying EBITDA of A$47 million, which is at the lower end of its guidance range. 
  • At first glance, FY25 results are positive for Mayne as they suggest that the weak 3Q was an aberration and its performance is on an upward trajectory. 
  • However, my analysis suggests that the results provide Cosette with several angles to pursue to bolster its case of a MAC breach. This remains a high-risk/high-reward set-up. 

HKBN (1310 HK): On the Cusp of Being Declared Unconditional

By Arun George

  • HKBN Ltd (1310 HK)’s offer from China Mobile (941 HK) is HK$5.075 with a 50% minimum acceptance condition. The first closing date is September 3.
  • Based on CCASS data, including acceptances, China Mobile’s shareholding was 48.93% of outstanding shares as of September 1.
  • Therefore, the offer should be declared unconditional by the first closing date. At the last close and for a September 12 payment, the gross/annualised spread is 0.5%/15.7%.

Clearing up the FSS’s Sudden Call on Samsung Life’s Samsung Elec Stake Accounting Shift

By Sanghyun Park

  • Today’s FSS IFRS17 ruling is an accounting fix (equity vs. liability), not the Samsung Life Law, which is a regulatory cap on affiliate stakes based on market value.
  • The FSS ruling signals Samsung Life doesn’t need to treat its Samsung Electronics stake as a forced-sale liability, lowering near-term sale risk.
  • This eases the overhang, delays potential stake moves, and reinforces the relative underperformance setup on Samsung C&T highlighted in earlier posts.

Current Merger Arbitrage Opportunities and Strategic Reviews in Global Markets: Key Active Cases

By Special Situation Investments

  • Apiam Animal Health received a takeover offer at A$0.88/share with an 11% spread, supported by founder Dr. Chris Richards.
  • Plymouth Industrial REIT has a $24.10/share bid from Sixth Street Capital, with a 14-15% spread and board review ongoing.
  • DallasNews has two takeover offers: $15/share from Hearst and $18.5/share from Alden, requiring two-thirds shareholder approval.

A/H Premium Tracker (To 29 Aug 2025):  AH Premia Expand Again, Beautiful Skew Takes a Breather

By Travis Lundy

  • HUGE, rampaging, “Beautiful Skew”… is flat. Big swings in H/A ratios continue, this time on average with 2.1% H underperformance vs As which is -4.4% on average over two weeks.
  • Last week’s short reco on Fuyao Glass Industry Group (3606 HK) was up 2.3% on the week in Hs but Hs underperformed the As by 1.86%.
  • AH premia are in a widening phase. This may continue. New reco this week.

Lynas (LYC AU) Targets Vertical Expansion

By David Blennerhassett

  • Last week, rare-earth play Lynas Corp Ltd (LYC AU) squared away a fully underwritten A$750mn placement (56.6mn shares, 6.1% of shares outstanding) at A$13.25/share, a 10% discount to last close. 
  • Gina Rinehart, Lynas’ second largest shareholders with ~8.2%, took up her compliment. 
  • Placement proceeds will be applied to streamlining ops, expanding its stockpiles/capacity, and investing downstream into magnet makers.

Huaxin Cement (6655 HK): Floats Non-Chinese Ops Spin-Off

By David Blennerhassett

  • Two days after announcing its 2025 interims, Holcim (HOLN SW)-backed Huaxin Cement (6655 HK) proposed spinning off its overseas cement assets.
  • The overseas ops, predominantly located in Africa, significantly outperformed the PRC ops in FY24, a trend that continued into 2025. 
  • No preferred bourse was stipulated, although the HKEx appears the logical choice. Pegged to historical trading metrics, Huaxin appears fully valued here.

Increasing Probability of Hanwha Group Selling Its 8% Stake in Korea Zinc

By Douglas Kim

  • There has been an increasing probability of the Hanwha Group selling its stake in Korea Zinc (010130 KS) mainly due to increasing burden of its petrochemical affiliates.
  • For now, the Hanwha Group has denied all news regarding its potential sale of stake in Korea Zinc.
  • In our view, the timing of this potential sale in Korea Zinc by Hanwha Group is less likely in 2025 but could occur in 2026/2027. 

Merger Arbitrage Opportunities and Strategic Updates: AHX, PLYM, LWAY, YORKU, NZM, PAC and More

By Special Situation Investments

  • Apiam Animal Health received a takeover offer from Adamantem Capital at A$0.88/share, with a current spread of 11%.
  • YORK announced a merger with CRO token issuance, with each YORK share representing approximately 47 CRO tokens.
  • Pacific Current Group’s FY25 results show a 28% discount to NAV, with potential capital allocation concerns.

Apiam Animal Health Receives A$0.88/Share Takeover Offer from Adamantem Capital

By Special Situation Investments

  • Apiam Animal Health received a takeover offer from Adamantem Capital at A$0.88/share, representing a 60% premium.
  • Adamantem has 30 days of exclusivity for due diligence, with support from AHX’s largest shareholder and founder.
  • AHX’s enterprise value is A$220m, aligning with Adamantem’s typical transaction size and strategic acquisition interests.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: [Japan M&A] Yutaka Giken (7229 JP) TOB – Possibly the Most Offensively Low TOB Price I’ve Ever Seen and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • [Japan M&A] Yutaka Giken (7229 JP) TOB – Possibly the Most Offensively Low TOB Price I’ve Ever Seen
  • Curator’s Cut: Arbs Go A-H, Copper Plays & China’s Property Pulse
  • Is NPS Really Going for Board Seat Play Via Cumulative Voting? Field Check on This Narrative
  • RPMGlobal (RUL AU): Caterpillar Mulling a Privatisation Bid
  • Merger Arb Mondays (01 Sep) – Dongfeng, ENN, Joy City, Kangji, Mayne, Santos, Shibaura, CareNet
  • (Mostly) Asia M&A, Aug 2025 Wrap: Dongfeng Motor, Kangji, Carenet, Nihon Chouzai, Technopro
  • Carved in Wood: Sidara’s Firm Offer, but Fragile Conditions


[Japan M&A] Yutaka Giken (7229 JP) TOB – Possibly the Most Offensively Low TOB Price I’ve Ever Seen

By Travis Lundy

  • Honda Motor (7267 JP) and Samvardhana Motherson International Ltd (MOTHERSO IN) have arranged to buy Honda’s 69.7%-owned subsidiary Yutaka Giken (7229 JP) in a Tender Offer. 
  • The transaction structure means Motherson buys Yutaka for less than net cash but even assuming Motherson pay minority TOB price for everything, TOB ex-net cash = 0.05x PBR, <1x EBITDA.
  • But they are paying less. They are paying ¥12.4bn less than net cash, and getting the other ¥58bn of net assets (¥23bn inventory, the rest in hard assets) for free.

Curator’s Cut: Arbs Go A-H, Copper Plays & China’s Property Pulse

By Pranav Rao

  • Welcome to Curator’s Cut, a fortnightly roundup of standout themes from the 1,200+ Insights published over the past two weeks on Smartkarma
  • In this cut, we explore A-H share trading dynamics, consider copper market dynamics and plays, and China’s bottoming/stabilizing real estate market
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next

Is NPS Really Going for Board Seat Play Via Cumulative Voting? Field Check on This Narrative

By Sanghyun Park

  • Short-Term, pinpointing exact tickers off this NPS/cumulative voting narrative is tough—activism risk is real, but predicting moves in governance-sensitive names is still premature.
  • NPS may go aggressive, potentially sparking a market-wide narrative. If limited activism unwinds, Korean stocks could see a broad re-rate, beyond just individual governance names.
  • Tactically, consider enhanced setups in these names under a passive framework, while closely monitoring governance developments and NPS-driven activism for actionable alpha in individual tickers.

RPMGlobal (RUL AU): Caterpillar Mulling a Privatisation Bid

By Arun George

  • The AFR reports that Caterpillar Inc (CAT US) and four other bidders are considering a privatisation bid for RPMGlobal Holdings Limited (RUL AU) at around A$5.00 per share.
  • In response to the article, RPM entered a trading halt the same day regarding “an indicative proposal from a third party regarding a potential acquisition.”  
  • RPM’s shareholder structure facilitates an offer. The rumoured offer is reasonable but is far from a knockout bid, suggesting the potential of a bidding war.  


(Mostly) Asia M&A, Aug 2025 Wrap: Dongfeng Motor, Kangji, Carenet, Nihon Chouzai, Technopro

By David Blennerhassett

  • For Aug 2025, 17 new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$18bn.
  • The average premium for the new transactions announced (or first discussed) in August was 48%, with a year-to-date average of 47%.
  • The average premiums for transactions in 2024 (129 transactions), (2023 (117), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) were 43%, 39%, 41%, 33%, 31%, and 31%

Carved in Wood: Sidara’s Firm Offer, but Fragile Conditions

By Jesus Rodriguez Aguilar

  • Sidara’s 30p/share offer, backed by $450m funding and debt extension, is the only viable path; yet “Exceptional Conditions” make this deal unusually binary despite board support.
  • The audit (clean FY24 balance sheet opinion by 31 Oct 2025) and A&E by 31 Dec 2025 are non-waivable gates; clearing both crystallizes 30p, missing either drives automatic lapse.
  • Probability-Weighted target price stands at 24.9p; distressed entries retain compelling upside, but pre-existing holders rely heavily on successful completion. Break risk implies severe equity impairment if conditions fail.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: (Mostly) Asia-Pac M&A: Santos and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • (Mostly) Asia-Pac M&A: Santos, Mayne Pharma, Shengjing Bank, Carenet, Austindo Nusantara, Ashimori
  • Last Week In Event SPACE: Dongfeng Motor, Shibaura, HD Hyundai Heavy/HD Hyundai Mipo, Zijin Mining
  • Weekly Deals Digest (31 Aug) – ENN Energy, Shengjing, Ashimori, Carenet, Shibaura, Mayne, Aux


(Mostly) Asia-Pac M&A: Santos, Mayne Pharma, Shengjing Bank, Carenet, Austindo Nusantara, Ashimori

By David Blennerhassett


Last Week In Event SPACE: Dongfeng Motor, Shibaura, HD Hyundai Heavy/HD Hyundai Mipo, Zijin Mining

By David Blennerhassett


Weekly Deals Digest (31 Aug) – ENN Energy, Shengjing, Ashimori, Carenet, Shibaura, Mayne, Aux

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars